Clinical Trial Update: Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958 [Phase 2]

View source ↗

Summary

Follow-up Phase 2 trial assessing the effect of GSK2245035 on nasal allergic reactivity in subjects completing treatment in a prior study; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• GSK2245035 (GSK2245035)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma and Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15